Features, pricing, ratings, and pros & cons — compared head-to-head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). Lyrie AI Security & Privacy Anti-Malware & Anti-AI is a commercial endpoint protection platform tool by Lyrie AI. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Tool that immunizes Windows systems against critical vulnerabilities
Multi-layered EPP/EDR for desktop & mobile with Anti-AI threat defense.
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs Lyrie AI Security & Privacy Anti-Malware & Anti-AI for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
Lyrie AI Security & Privacy Anti-Malware & Anti-AI: Multi-layered EPP/EDR for desktop & mobile with Anti-AI threat defense. built by Lyrie AI. Core capabilities include Multi-layered real-time protection across file creation, download, and modification, Behavioral detection engine with process chain analysis and lateral movement tracking, Anti-AI engine defending against prompt injection, agent exploitation, and identity poisoning..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Lyrie AI Security & Privacy Anti-Malware & Anti-AI differentiates with Multi-layered real-time protection across file creation, download, and modification, Behavioral detection engine with process chain analysis and lateral movement tracking, Anti-AI engine defending against prompt injection, agent exploitation, and identity poisoning.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Lyrie AI Security & Privacy Anti-Malware & Anti-AI is developed by Lyrie AI. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
360 High-Risk Vulnerability Immunization Tool V2.0 and Lyrie AI Security & Privacy Anti-Malware & Anti-AI serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox